Australia markets close in 2 hours 7 minutes

Knight Therapeutics Inc. (GUD.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
5.73-0.14 (-2.39%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
332,206
328,199
293,563
243,478
199,519
-
Cost of revenue
178,617
175,547
155,502
128,066
117,829
-
Gross profit
153,589
152,652
138,061
115,412
81,690
-
Operating expenses
Research development
18,342
17,549
14,755
12,692
11,725
-
Selling general and administrative
87,109
83,693
88,624
74,376
74,430
-
Total operating expenses
150,192
146,282
155,121
128,244
111,690
-
Operating income or loss
3,397
6,370
-17,060
-12,832
-30,000
-
Interest expense
12,274
12,488
6,600
3,618
3,398
-
Total other income/expenses net
-27,173
-28,445
-30,932
15,758
51,161
-
Income before tax
-24,186
-21,988
-43,960
6,690
32,085
-
Income tax expense
-6,742
-5,153
-14,068
-8,985
325
-
Income from continuing operations
-17,444
-16,835
-29,892
15,675
31,760
-
Net income
-17,444
-16,835
-29,892
15,675
42,067
-
Net income available to common shareholders
-17,444
-16,835
-29,892
15,675
42,067
-
Basic EPS
-0.06
-
-0.26
0.13
0.32
0.10
Diluted EPS
-0.06
-
-0.26
0.13
0.32
0.10
Basic average shares
109,759
-
114,890
124,480
131,783
139,759
Diluted average shares
109,931
-
114,890
124,522
131,985
140,139